These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 4190429)

  • 1. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies with a new beta receptor blocking agent from the indole series (LB 46)].
    Sterz H
    Wien Klin Wochenschr; 1970 Dec; 82(50):894-9. PubMed ID: 4099292
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
    Nellen M
    S Afr Med J; 1969 Dec; ():Suppl:15-7. PubMed ID: 4392020
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and experimental experience with 39089 BA (trasicor) as an anti-arrhythmic agent.
    Obel IW
    S Afr Med J; 1969 Dec; ():Suppl:18-23. PubMed ID: 4392021
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of propranolol in the treatment of angina pectoris and cardiac arrhythmias.
    Chhetri MK; Neelkantan C; Guha SR
    Indian Heart J; 1969 Jul; 21(3):273-86. PubMed ID: 4189137
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 7. The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
    Robson RD; Kaplan HR
    J Pharmacol Exp Ther; 1970 Oct; 175(1):157-67. PubMed ID: 4394301
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of isoptin in angina pectoris and heart rhythm disorders].
    Doshchitsyn VL; Arshakuni RO; Zharov EI
    Kardiologiia; 1967 Aug; 7(8):32-40. PubMed ID: 4182174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical use of propranolol (Inderal)].
    Doshchitsin VL; Zharov EI; Arshakuni RO
    Kardiologiia; 1967 Oct; 7(10):59-67. PubMed ID: 4179686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of cardiac arrhythmias with practolol, a new heart specific beta receptor blocking agent].
    Amor H; Schwingshackl H; Wilflingseder S; Dienstl F
    Dtsch Med Wochenschr; 1971 Jun; 96(25):1069-75. PubMed ID: 4103499
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacology of practolol, a cardioselective beta adrenergic blocking drug.
    Fitzgerald JD
    Acta Cardiol; 1972; Suppl 16():1-18. PubMed ID: 4405742
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV
    J Clin Pharmacol New Drugs; 1971; 11(4):249-60. PubMed ID: 4397374
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.
    Ablad B; Brogård M; Ek L
    Acta Pharmacol Toxicol (Copenh); 1967; 25():9-40. PubMed ID: 6072577
    [No Abstract]   [Full Text] [Related]  

  • 16. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P; Laddu AR; Hardm HF
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract]   [Full Text] [Related]  

  • 17. [The acute effects of beta-adrenergic blocking agents].
    Grandjean T
    Schweiz Med Wochenschr; 1967 Nov; 97(47):1559-64. PubMed ID: 4174747
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of tachycardiac arrhythmias].
    Bender F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():97-105. PubMed ID: 4191388
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.